BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2399692)

  • 21. Monocyte monolayer assay (MMA) reactivity of alloantibodies reacting by the manual polybrene technique but not by an antiglobulin test.
    Lown J; Willis J
    Transfus Med; 1995 Dec; 5(4):281-4. PubMed ID: 8646292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of severity of haemolytic disease of newborn by monocyte monolayer assay.
    Dhingra-Kumar N; Duguid JK; Bromilow IM
    Indian J Med Res; 1995 Aug; 102():71-6. PubMed ID: 8834817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn.
    Brouwers HA; Overbeeke MA; Ouwehand WH; Keuning K; van Ertbruggen I; van Leeuwen EF; Stoop JW; Engelfriet CP
    Br J Haematol; 1988 Dec; 70(4):465-9. PubMed ID: 3219297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies.
    Neppert J; Kissel K
    Lancet; 1992 Jun; 339(8807):1481. PubMed ID: 1351152
    [No Abstract]   [Full Text] [Related]  

  • 25. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn.
    Sacks DA; Nance SJ; Garratty G; Petrucha RA; Horenstein J; Fotheringham N
    Am J Perinatol; 1993 Nov; 10(6):428-31. PubMed ID: 8267805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild course of fetal RhD haemolytic disease due to maternal alloimmunisation to paternal HLA class I and II antigens.
    Eichler H; Zieger W; Neppert J; Kerowgan M; Melchert F; Goldmann SF
    Vox Sang; 1995; 68(4):243-7. PubMed ID: 7660645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe ABO haemolytic disease due to high titre IgG anti-B in an A2 mother.
    Graham H; Morrison M; Casey E
    Vox Sang; 1974; 27(4):363-8. PubMed ID: 4213379
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunoglobulin G subclasses and isoimmunized pregnancy outcome.
    Taslimi MM; Sibai BM; Mason JM; Dacus JV
    Am J Obstet Gynecol; 1986 Jun; 154(6):1327-32. PubMed ID: 3717242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocyte-erythrocyte interaction in autoimmune haemolytic anaemia in relation to the number of erythrocyte-bound IgG molecules and subclass specificity of autoantibodies.
    ZupaƄska B; Brojer E; Thomson EE; Merry AH; Seyfried H
    Vox Sang; 1987; 52(3):212-8. PubMed ID: 3604180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An enzyme-linked immunosorbent assay for the quantitation of IgG anti-D and IgG subclasses in the sera of alloimmunized patients.
    Lambin P; Ahaded A; Debbia M; Lauroua P; Rouger P
    Transfusion; 1998 Mar; 38(3):252-61. PubMed ID: 9563405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective study of red cell maternal antibodies by chemiluminescence.
    Downing I; Bromilow IM; Templeton JG; Fraser RH
    Vox Sang; 1996; 71(4):226-32. PubMed ID: 8958647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG3 anti-Kell allotypic variation results in differential antigen binding and phagocytosis.
    Cen SY; Holton MB; Binnington B; Denomme GA; Howie HL; Lebedev JN; Zimring JC; Branch DR
    Transfusion; 2020 Apr; 60(4):688-693. PubMed ID: 31930726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
    Brinc D; Lazarus AH
    Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoimmunization in pregnancy to Gerbich antigen.
    Sacks DA; Johnson CS; Platt LD
    Am J Perinatol; 1985 Jul; 2(3):208-10. PubMed ID: 4015769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?
    Brinc D; Le-Tien H; Crow AR; Freedman J; Lazarus AH
    Br J Haematol; 2007 Oct; 139(2):275-9. PubMed ID: 17897303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An explanation of the failure of the direct antiglobulin test to detect erythrocyte sensitization in ABO haemolytic disease of the newborn and observations on pinocytosis of IgG anti-A antibodies by infant (cord) red cells.
    Voak D; Williams MA
    Br J Haematol; 1971 Jan; 20(1):9-23. PubMed ID: 5099693
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn.
    Pollock JM; Bowman JM
    Vox Sang; 1990; 59(3):176-9. PubMed ID: 2124753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation.
    Garner SF; Wiener E; Contreras M; Nicolini U; Kochenour N; Letsky E; Rodeck CH
    Br J Haematol; 1992 Jan; 80(1):97-101. PubMed ID: 1536816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocyte ingestion of IgG-coated erythrocytes from haemolysing and non-haemolysing subjects.
    Mason DY
    Acta Haematol; 1976; 55(1):1-9. PubMed ID: 816133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.